異檸檬酸脫氫酶1乙酰化修飾調控其活性機制的研究
首發時間:2025-08-19
景禧鳳(2000-),女,碩士研究生,翻譯后修飾
陳冬 1陳冬(1982-),男,教授、博導,免疫細胞代謝
摘要:異檸檬酸脫氫酶1(Isocitrate Dehydrogenase1, IDH1)是位于胞質中的關鍵代謝酶,參與三羧酸循環中異檸檬酸氧化脫羧生成a-酮戊二酸(a-KG)的反應,并同時催化NADP+還原為NADPH。盡管近年來研究發現IDH1存在多個乙酰化修飾位點,并初步揭示了這些修飾在腫瘤代謝、氧化應激等方面的調控作用,但不同位點乙酰化的分子機制及其在腫瘤治療中的潛在價值仍需進一步闡明。本文通過去乙酰化酶抑制劑處理發現膠質瘤細胞中IDH1存在乙酰化修飾,酶促反應動力學檢測比較體外純化的野生型和突變體蛋白酶活性發現K374去乙酰化后顯著抑制IDH1酶活性,而乙酰化修飾則對IDH1活性有促進作用,體外NADP+結合實驗表現出IDH1 K374R突變蛋白(模擬去乙酰化突變)與NADP+結合受阻,顯著抑制腫瘤細胞增殖能力。本研究闡明IDH1 K374位點乙酰化通過調節酶活性可能影響腫瘤發生發展的新機制,拓展了IDH1在腫瘤中功能的認識,并提示IDH1 K374位點的乙酰化修飾可能成為IDH1野生型腫瘤的潛在治療靶點。
For information in English, please click here
Study on the Regulatory Mechanism of Isocitrate Dehydrogenase1 Activity through Acetylation Modification
景禧鳳(2000-),女,碩士研究生,翻譯后修飾
Dong Chen 1陳冬(1982-),男,教授、博導,免疫細胞代謝
Abstract:Isocitrate Dehydrogenase1 (IDH1) is a key metabolic enzyme located in the cytoplasm that is involved in the oxidative decarboxylation of isocitrate to produce a-ketoglutarate (a-KG) in the tricarboxylic acid cycle and catalyzes the reduction of NADP+ to NADPH. Although studies in recent years have revealed the existence of multiple acetylation modification sites in IDH1 and initially revealed the regulatory roles of these modifications in tumor metabolism, oxidative stress, etc., the molecular mechanisms of acetylation at different sites and their potential value in tumor therapy still need to be further elucidated. In this paper, the acetylation modification of IDH1 in glioma cells was detected by treatment with deacetylase inhibitors, and the enzyme kinetic assay comparing in vitro purified wild-type and mutant protease activities revealed that K374 deacetylation significantly inhibited IDH1 enzyme activity, while the acetylation modification had a promotional effect on IDH1 activity, and the in vitro NADP+ binding assay showed that the IDH1 K374R mutated protein (mimicking deacetylated mutant) was not able to regulate tumor metabolism and oxidative stress. In vitro NADP+ binding assay showed that IDH1 K374R mutated protein (mimicking deacetylation mutation) was blocked from binding to NADP+, and significantly inhibited tumor cell proliferation. The present study elucidates a new mechanism by which IDH1 K374 acetylation affects tumor metabolism and progression through the regulation of enzyme activity, expanding the understanding of IDH1 function in tumors and suggesting that acetylation modification of the IDH1 K374 site may be a potential therapeutic target for IDH1 wild-type tumors.
Keywords: IDH1 acetylation modification tumor cell proliferation
基金:
引用

No.****
動態公開評議
共計0人參與
勘誤表
異檸檬酸脫氫酶1乙酰化修飾調控其活性機制的研究
評論
全部評論